Yoo Sonia H, Bhatt Anand B
Bascom Palmer Eye Institute, Florida, USA.
Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):173-4. doi: 10.3928/15428877-20070301-18.
The authors report surgical experience and clinical outcomes up to 1 year postoperatively in patients who underwent cataract surgery with the AquaLase liquefaction device (Alcon Laboratories, Fort Worth, TX). The device is a handpiece option for use with Alcon's Infiniti Vision System that uses heated balanced saline solution micropulses to liquefy lenticular material. Twenty-seven eyes of 23 patients underwent cataract extraction with the use of the AquaLase liquefaction device. The average age of participants was 68 years, and the average nuclear sclerotic grade was 1.96 on a 4-point scale. Outcomes were judged by metrics such as visual acuity, inflammation, endothelial cell count, and postoperative posterior capsule opacification. At 30 days postoperatively, 78% of eyes had a best-corrected visual acuity of 20/20. Visual acuity was 20/25 or better 1 year postoperatively in 88% of patients without complications except conversion to ultrasound phacoemulsification for two dense cataracts.
作者报告了使用AquaLase液化设备（爱尔康实验室，沃思堡，德克萨斯州）进行白内障手术的患者术后长达1年的手术经验和临床结果。该设备是爱尔康Infiniti视觉系统的一种手持部件选项，它使用加热的平衡盐溶液微脉冲来液化晶状体物质。23例患者的27只眼睛使用AquaLase液化设备进行了白内障摘除术。参与者的平均年龄为68岁，平均核硬化等级在4分制中为1.96。通过视力、炎症、内皮细胞计数和术后后囊膜混浊等指标来判断结果。术后30天时，78%的眼睛最佳矫正视力为20/20。在没有并发症的患者中，除了因两颗致密白内障转为超声乳化手术外，88%的患者术后1年视力为20/25或更好。
